10.6084/m9.figshare.5992117.v1
Peter Nash
Peter
Nash
Philip Mease
Philip
Mease
Iain McInnes
Iain
McInnes
Proton Rahman
Proton
Rahman
Christopher Ritchlin
Christopher
Ritchlin
Ricardo Blanco
Ricardo
Blanco
Eva Dokoupilova
Eva
Dokoupilova
Mats Andersson
Mats
Andersson
Radhika Kajekar
Radhika
Kajekar
Shephard Mpofu
Shephard
Mpofu
Luminita Pricop
Luminita
Pricop
Additional file 1: of Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)
Springer Nature
2018
Psoriatic arthritis
Secukinumab
Autoinjector
Interleukin-17a
FUTURE 3 study
2018-03-15 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Efficacy_and_safety_of_secukinumab_administration_by_autoinjector_in_patients_with_psoriatic_arthritis_results_from_a_randomized_placebo-controlled_trial_FUTURE_3_/5992117
Figure S1. Showing study design, Table S1. Presenting independent ethics committees (IECs) or institutional review boards (IRB) by study center, Table S2. Presenting a summary of observed efficacy data at week 52 among patients randomized to secukinumab at baseline, Table S3. Presenting patient-reported acceptability of the autoinjector, and Table S4. Presenting SAEs by SOC reported across the entire study period. (DOCX 438 kb)